Recruitment target and sites

Find out the trial target recruitment and which sites are recruiting

Recruitment

Deep Immunophenotyping Group: Target 150 patients in each cohort

• Rheumatic/Inflammatory conditions
• Cancer
• Chronic liver conditions and inflammatory bowel disease
• Chronic renal conditions
• Haematopoietic stem cell transplant (HSCT) and chimeric antigen receptor (CAR) T cell recipients
• Rheumatic, liver and renal conditions are closed

Serology Group: 850 patients in each cohort

• Rheumatic/Inflammatory conditions
• Cancer
• Chronic liver conditions and inflammatory bowel disease
• Chronic renal conditions
• Haematopoietic stem cell transplant (HSCT) and chimeric antigen receptor (CAR) T cell recipients
• Renal conditions is closed

Participating sites

Principal Investigators and their main associated site

Site Name	Principal Investigator
Addenbrooke’s Hospital, Cambridge	Dr Ram Malladi
Glasgow Royal Infirmary, Glasgow	Professor Stefan Siebert
Hammersmith Hospital, London	Dr Michelle Willicombe & Dr David Thomas
John Radcliffe Hospital, Oxford	Professor Eleanor Barnes
King’s College Hospital, London	Dr Robin Sanderson
Queen Elizabeth Hospital, Birmingham	Professor Daniel Rea
Royal Hallamshire Hospital, Sheffield	Professor John Snowden
Southampton General Hospital, Southampton	Dr Kim Orchard
St James’s University Hospital, Leeds	Professor Gordon Crook

Participant Identification Centres (PIC)

• Royal Berkshire NHS Foundation Trust
• Milton Keynes University Hospital NHS Foundation Trust